OOIR: Observatory of International Research

Papers

(The H4-Index of Current Oncology Reports is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	137
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	135
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	89
New Developments in VHL-Associated Neuroendocrine Neoplasms	89
Management of Upper Tract Urothelial Carcinoma	83
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	74
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	70
Brain Prehabilitation for Oncologic Surgery	66
Immunotherapy in Biliary Tract Cancers: Where Are We?	58
NRG1 Fusions: The New Kid on the Block	54
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	51
New Insights on Tramadol and Immunomodulation	50
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	43
Treatment of Metastatic Melanoma in the Elderly	41
Fatty Acid Metabolism and Cancer Immunotherapy	41
Surgical Management of Melanoma: Advances and Updates	37
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	37
Management of In-Transit Metastases	35
Current Trends and Challenges of Microbiome Research in Prostate Cancer	35
Prostate Cancer Immunotherapy—Finally in From the Cold?	35
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	35
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	35
An Overview of Angiogenesis in Bladder Cancer	34
Head and Neck Mucosal Melanoma: Where Are We Now?	32
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	31

Cellular Therapy in NSCLC: Between Myth and Reality	31
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	31
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	31
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	31
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	31
Anti-PD-1: When to Stop Treatment	30